35 reports of this reaction
5.1% of all NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND HYDROCORTISONE reports
#1 most reported adverse reaction
EAR DISCOMFORT is the #1 most commonly reported adverse reaction for NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND HYDROCORTISONE, manufactured by Amneal Pharmaceuticals NY LLC. There are 35 FDA adverse event reports linking NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND HYDROCORTISONE to EAR DISCOMFORT. This represents approximately 5.1% of all 690 adverse event reports for this drug.
Patients taking NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND HYDROCORTISONE who experience ear discomfort should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
EAR DISCOMFORT is moderately reported among NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND HYDROCORTISONE users, representing a notable but not dominant share of adverse events.
In addition to ear discomfort, the following adverse reactions have been reported for NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND HYDROCORTISONE:
The following drugs have also been linked to ear discomfort in FDA adverse event reports:
EAR DISCOMFORT has been reported as an adverse event in 35 FDA reports for NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND HYDROCORTISONE. This does not prove causation, but indicates an association observed in post-market surveillance data.
EAR DISCOMFORT accounts for approximately 5.1% of all adverse event reports for NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND HYDROCORTISONE, making it one of the most commonly reported side effect.
If you experience ear discomfort while taking NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND HYDROCORTISONE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.